Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2146 studies found for:    HIV [CONDITION] AND NIH [SPONSOR-COLLABORATORS-CLASS] NOT NIMH [ORGANIZATION-NAME]
Show Display Options
Rank Status Study
21 Completed A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women
Condition: HIV Infections
Interventions: Drug: Abacavir sulfate;   Drug: Zidovudine
22 Completed A Blood Test to Look at Cells of the Immune System in Healthy Children
Conditions: HIV Infections;   HIV Seronegativity
Intervention:
23 Completed Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents
Condition: HIV Infections
Intervention: Drug: Abacavir sulfate
24 Completed
Has Results
Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth
Condition: HIV Infections
Interventions: Drug: Didanosine, enteric-coated;   Drug: Lopinavir/ritonavir;   Drug: Nevirapine;   Drug: Zidovudine
25 Completed Hormonal Birth Control and the Risk of Acquiring HIV
Condition: HIV Infections
Interventions: Drug: Ethinyl estradiol/levonorgestrel;   Drug: Medroxyprogesterone acetate
26 Completed Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive Children
Condition: HIV Infections
Interventions: Drug: Nelfinavir mesylate;   Drug: Efavirenz
27 Completed Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens
Condition: HIV Infections
Interventions: Drug: Ritonavir;   Drug: Nelfinavir mesylate;   Drug: Nevirapine;   Drug: Lamivudine;   Drug: Stavudine
28 Completed Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs
Condition: HIV Infections
Interventions: Drug: Didanosine;   Drug: Efavirenz;   Drug: Emtricitabine
29 Completed Zidovudine and Lamivudine Given Once Versus Twice Daily
Condition: HIV Infections
Intervention: Drug: Lamivudine/Zidovudine
30 Completed The Effects of Anti-HIV Therapy on the Immune Systems of Children and Young Adults Infected With HIV
Condition: HIV Infections
Interventions: Biological: Tetanus toxoid;   Biological: Hepatitis A Vaccine (Inactivated)
31 Completed Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs
Condition: HIV Infections
Intervention:
32 Completed Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems
Condition: HIV Infections
Interventions: Biological: Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed;   Biological: Diphtheria and Tetanus Toxoids Adsorbed;   Biological: Tetanus and Diphtheria Toxoids Adsorbed;   Drug: Bacteriophage phi X 174;   Drug: Aldesleukin
33 Completed A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers
Conditions: HIV Infections;   HIV Seronegativity
Interventions: Biological: ALVAC(2)120(B,MN)GNP (vCP1452);   Biological: MN rgp120/HIV-1 and GNE8 rgp120/HIV-1;   Biological: ALVAC-HIV MN120TMG (vCP205)
34 Completed A Study to Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected Children
Condition: HIV Infections
Intervention: Drug: Aldesleukin
35 Completed Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery
Condition: HIV Infections
Intervention: Drug: Tenofovir 1% vaginal gel
36 Completed HIV Prevention Preparedness Study in Russia, China, and India
Condition: HIV Infections
Intervention:
37 Withdrawn Safety, Tolerability, Drug Interactions, and Antiviral Activity of Rilpivirine in Antiretroviral-Naive HIV-Infected Children Less Than 12 Years of Age
Condition: HIV Infections
Intervention: Drug: Rilpivirine
38 Active, not recruiting Safety and Effectiveness of Oral Alendronate Therapy on Bone Mineral Density in HIV-infected Children and Adolescents With Low Bone Mineral Density
Condition: HIV Infections
Interventions: Drug: Alendronate;   Drug: Alendronate placebo;   Dietary Supplement: Calcium carbonate/vitamin D
39 Completed
Has Results
Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents
Condition: HIV Infections
Intervention: Drug: Vicriviroc
40 Active, not recruiting
Has Results
Safety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and Adolescents
Condition: HIV Infections
Interventions: Drug: Raltegravir poloxamer film coated tablet;   Drug: Raltegravir chewable tablet;   Drug: Raltegravir oral granules for suspension (20 mg/mL)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.